Patent quality is a concept used by many different stakeholders, but not easily defined. There are a variety of different perspectives:
- Patent offices often think of patent quality in terms of streamlined and timely patent search and examination procedures.
- Companies have their own, often different, understanding of patent quality focusing on fitness for purpose to support targeted IP strategies.
- Users of IP may understand patent quality as the set of positive economic outcomes produced by the patent system.
The granting of patents with a high chance of validity is crucial to consistent, predictable and efficient court decisions in patent lawsuits, and the good functioning of the patent system in general. The outcome of the patenting process, from proper drafting by the applicant to thorough examination by the patent offices, including the European Patent Office, should be patents with reliable validity. If this is lacking, there are serious consequences. For instance, the bifurcated German patent court system creates the so called “injunction gap”, caused by slow decisions on validity by the BPatG on the one hand and the relative speed of infringement decisions by Civil Courts on the other. This gap creates considerable uncertainty for industry and skewed outcomes, as well as criticism among users and observers of the patent system. This uncertainty would be reduced significantly if patents could be more reliably considered prima facie valid from grant.
However, the burden to improve the situation is not only on the authorities’ side e.g., by improving the examination and litigation processes and providing the necessary resources for the courts. The users of the system must also contribute to the efficiency and the transparency of the patent system by focusing their IP generation and portfolio management on patent quality rather than quantity.
We, the undersigned companies therefore voluntarily adhere to the following Industry Patent Quality Charter and declare that:
- Patent quality is a crucial element of the health of the IP system. High numbers of patents are neither cost effective nor a primary goal.
- We focus our patent filings on inventions that add sustained value to improve our company’s and our customer’s products and services.
- A high rank in the patent application filing statistics of the patent offices is not our priority.
- We regularly review our patent portfolios and adapt the number of existing patents to that needed to support our businesses, thus freeing up space for others in the IP system.
- We ensure proper information for the public by striving for clearly written patents with a well-defined scope of protection, avoiding misleading or inconsistent wording.
Signatories
Amaury Claudel
Chief Patent Counsel
ATOS
Jörg Thomaier
Head of IP Bayer Group
Bayer AG
Stephan Altmeyer
VP Patent & Brand
Deutsche Telekom AG
Gerhard Guthöhrlein
Head of Intellectual Property Europe
Drägerwerk AG & Co. KGaA
Christina Schäfer
Head of Patent Strategy & Management
dSPACE GmbH
Gabriele Mohsler
VP Patent Development
Ericsson
Andreas Poredda
Chief Patent Officer
F. Hoffmann-La Roche AG
Thomas Spernat
Head of IP
Heraeus Business Solutions GmbH
Richard Lloyd
Patent Development Director - Global Legal Affairs
HP Inc.
Matthias Burkhardt
Senior Patent Counsel | Intellectual Property
Inventronics GmbH
Gianluca Previti
Head of Intellectual Property
Iveco Group N.V.
Christian Hamann
Vice President Corporate IP
Knorr-Bremse AG
Fabien Müller
Deputy HO Intellectual Property
Lilium GmbH
Christian Grünberger
Director Intellectual Property
MTU Aero Engines AG
Tuomas Saukkonen
Head of Cellular Standards Portfolio
Nokia Technologies Oy
Frank Oster
Director Intellectual Property - Global
Physik Instrumente (PI)
Veronique Kremer
Senior Director and Associate General Counsel, Europe & AMA
Procter & Gamble Company
Fabian Gonell
SVP, Licensing Strategy
Qualcomm Qualcomm Inc. GmbH & Co. KG
Andreas Hoferer
Vice President Intellectual Property
Schaeffler Automotive Buehl GmbH & Co. KG
Beat Weibel
Chief IP Counsel
Siemens AG
Markus Simon
Head of Intellectual Property
Siemens Healthcare Innovation GmbH&Co.KG
Filip De Corte
Head of IP
Syngenta Crop Protection AG
Tim Bast
Vice President Legal Affairs, Intellectual Property Rights
Tetra Pak Group
Jochen Meyer
Vodafone GmbH
Linus Eklund
Vice President Patents
Volvo Group
You want to become a signatory of the IPQC or you are interested in more information? We are looking forward to your message. Please use the contact form.